All News

An expert shares information on risk factors and controversies around testing.

Ideally, older patients receive vaccinations by October, but disease activity often peaks in February or March.

Results of the ACTIV-6 study showed that high dose ivermectin use did not demonstrate a clinical benefit for mild to moderate COVID-19.

Hospitals, health systems, and the supply chain are all negatively impacted by drug shortages and are each affected by the decisions of the others.

Products range from Parkinson disease treatment to medication for epilepsy.

Cognitive performance was higher if a person maintained physical activity throughout their lifetime.

Increasing interventions for affordable housing and food security could contribute to reduced rates of heart disease in lower income communities.

Pharmacy technicians and pharmacy technician leadership from UPMC Presbyterian discuss how they became pharmacy technicians in health-system pharmacies.

If approved, the vaccine would be the first immunization for use in pregnant individuals to help protect against the complications of respiratory syncytial virus in infants from birth through 6 months.

Substance use disorder is a significant social, economic, and public health crisis, with far too few individuals receiving the treatment they need, particularly among communities of color.

Understanding the complicated web of insurers, discounts from government and commercial plans, and payer access is extremely complicated.

In a subgroup analysis, patients with COVID-19 who received conventional oxygen support also benefitted, having 20 fewer deaths per 1000 patients when given remdesivir.

Products include medications for depressive disorder and migraines.

Autoimmune diseases are often chronic conditions that can evolve, so minimizing damage and progression is typically the mainstay of treatment.

Pharmacologic approaches can reduce the risk of chronic GVHD.

Sparsentan decreased proteinuria by nearly 50% in patients with IgA nephropathy, which may slow kidney function decline.

Positive data on the novel prostate cancer combination treatment was presented at the 2023 American Society of Clinical Oncology Genitourinary Cancers Symposium.

Case studies highlight questions about shingles.

Strategies to enhance patient relationships include teach-back method, providing follow-up information.

Current treatment options for depression lead to discontinuation because they are slower to work and have worse adverse event profiles.

Artificial intelligence is allowing researchers to redesign the interaction between the immune system and the protein of an allergen to safely overcome symptoms.

Olaparib with abiraterone increased survival in patients with metastatic prostate cancer compared to the current standard of care, according to a session at the ASCO Genitourinary Cancers Symposium.

The ability—or lack thereof—to procure drugs can drive prices up and decrease patient accessibility.

New research from Harvard Medical School could be a game changer for the management of headaches associated with anti-CGRP migraine therapy.

With recent outbreaks of measles and other vaccine-preventable diseases, vaccinations are more important than ever.

The FDA approved darolutamide in 2019 for the treatment of patients with nonmetastatic castration-resistant prostate cancer based improved metastasis-free survival.

Oncology pharmacists are as diverse as the cancers they manage and have key roles in the following areas of the cancer care continuum.

Ronna Hauser of the National Community Pharmacists Association discusses how pharmacists should prepare for DIR fee changes with guests from NCPA.